Trial Profile
A Phase IIa Study To Investigate The Effects of AER 001 on Antigen Challenge In Atopic Asthmatic Subjects Following Repeated Administration.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jan 2016
Price :
$35
*
At a glance
- Drugs Pitrakinra (Primary)
- Indications Allergic asthma; Asthma
- Focus Therapeutic Use
- Sponsors Aerovance
- 28 Sep 2007 New trial record.